ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Closed-loop Automated Insulin Delivery (AID) System Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-31Q16705
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Closed loop Automated Insulin Delivery AID System Market Research Report 2024
BUY CHAPTERS

Global Closed-loop Automated Insulin Delivery (AID) System Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-31Q16705
Report
November 2025
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd
Medtrum

Closed-loop Automated Insulin Delivery (AID) System Market

The global Closed-loop Automated Insulin Delivery (AID) System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help control blood glucose levels, reduce hypoglycemia, and increase time in range. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.
From a downstream perspective, Children with Type 1 Diabetes accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Closed-loop Automated Insulin Delivery (AID) System leading manufacturers including Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum, etc., dominate supply; the top five capture approximately % of global revenue, with Medtronic leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Closed-loop Automated Insulin Delivery (AID) System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Closed-loop Automated Insulin Delivery (AID) System Market Report

Report Metric Details
Report Name Closed-loop Automated Insulin Delivery (AID) System Market
Segment by Type
  • Hybrid Closed Loop Systems
  • DIY Closed Loop Systems
Segment by Application
  • Children with Type 1 Diabetes
  • Adults with Type 1 Diabetes
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Closed-loop Automated Insulin Delivery (AID) System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Closed-loop Automated Insulin Delivery (AID) System Market report?

Ans: The main players in the Closed-loop Automated Insulin Delivery (AID) System Market are Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum

What are the Application segmentation covered in the Closed-loop Automated Insulin Delivery (AID) System Market report?

Ans: The Applications covered in the Closed-loop Automated Insulin Delivery (AID) System Market report are Children with Type 1 Diabetes, Adults with Type 1 Diabetes

What are the Type segmentation covered in the Closed-loop Automated Insulin Delivery (AID) System Market report?

Ans: The Types covered in the Closed-loop Automated Insulin Delivery (AID) System Market report are Hybrid Closed Loop Systems, DIY Closed Loop Systems

1 Study Coverage
1.1 Introduction to Closed-loop Automated Insulin Delivery (AID) System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Hybrid Closed Loop Systems
1.2.3 DIY Closed Loop Systems
1.3 Market Segmentation by Application
1.3.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Children with Type 1 Diabetes
1.3.3 Adults with Type 1 Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Estimates and Forecasts 2020-2031
2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Closed-loop Automated Insulin Delivery (AID) System Sales Estimates and Forecasts 2020-2031
2.4 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Closed-loop Automated Insulin Delivery (AID) System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Hybrid Closed Loop Systems Market Size by Manufacturers
3.5.2 DIY Closed Loop Systems Market Size by Manufacturers
3.6 Global Closed-loop Automated Insulin Delivery (AID) System Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Type (2020-2031)
6.4 North America Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Type (2020-2031)
7.4 Europe Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Type (2020-2031)
9.4 Central and South America Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.1.4 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales by Product in 2024
11.1.6 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales by Application in 2024
11.1.7 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales by Geographic Area in 2024
11.1.8 Medtronic Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Tandem Diabetes Care
11.2.1 Tandem Diabetes Care Corporation Information
11.2.2 Tandem Diabetes Care Business Overview
11.2.3 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.2.4 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales by Product in 2024
11.2.6 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales by Application in 2024
11.2.7 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales by Geographic Area in 2024
11.2.8 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
11.2.9 Tandem Diabetes Care Recent Developments
11.3 Admetsys
11.3.1 Admetsys Corporation Information
11.3.2 Admetsys Business Overview
11.3.3 Admetsys Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.3.4 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales by Product in 2024
11.3.6 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales by Application in 2024
11.3.7 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales by Geographic Area in 2024
11.3.8 Admetsys Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
11.3.9 Admetsys Recent Developments
11.4 Insulet
11.4.1 Insulet Corporation Information
11.4.2 Insulet Business Overview
11.4.3 Insulet Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.4.4 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales by Product in 2024
11.4.6 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales by Application in 2024
11.4.7 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales by Geographic Area in 2024
11.4.8 Insulet Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
11.4.9 Insulet Recent Developments
11.5 Defymed
11.5.1 Defymed Corporation Information
11.5.2 Defymed Business Overview
11.5.3 Defymed Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.5.4 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales by Product in 2024
11.5.6 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales by Application in 2024
11.5.7 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales by Geographic Area in 2024
11.5.8 Defymed Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
11.5.9 Defymed Recent Developments
11.6 Beta Bionics (iLet)
11.6.1 Beta Bionics (iLet) Corporation Information
11.6.2 Beta Bionics (iLet) Business Overview
11.6.3 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.6.4 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Beta Bionics (iLet) Recent Developments
11.7 Bigfoot Biomedical
11.7.1 Bigfoot Biomedical Corporation Information
11.7.2 Bigfoot Biomedical Business Overview
11.7.3 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.7.4 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Bigfoot Biomedical Recent Developments
11.8 Dexcom
11.8.1 Dexcom Corporation Information
11.8.2 Dexcom Business Overview
11.8.3 Dexcom Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.8.4 Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Dexcom Recent Developments
11.9 MicroTech Medical (Hangzhou) Co., Ltd.
11.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Corporation Information
11.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Business Overview
11.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments
11.10 Medtrum
11.10.1 Medtrum Corporation Information
11.10.2 Medtrum Business Overview
11.10.3 Medtrum Closed-loop Automated Insulin Delivery (AID) System Product Models, Descriptions and Specifications
11.10.4 Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Medtrum Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Closed-loop Automated Insulin Delivery (AID) System Industry Chain
12.2 Closed-loop Automated Insulin Delivery (AID) System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Closed-loop Automated Insulin Delivery (AID) System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Closed-loop Automated Insulin Delivery (AID) System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Closed-loop Automated Insulin Delivery (AID) System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Closed-loop Automated Insulin Delivery (AID) System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Medtronic Inc
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd
Medtrum
List of Tables
 Table 1. Global Closed-loop Automated Insulin Delivery (AID) System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Closed-loop Automated Insulin Delivery (AID) System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Closed-loop Automated Insulin Delivery (AID) System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region (2020-2025) & (K Units)
 Table 8. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Closed-loop Automated Insulin Delivery (AID) System Sales Share by Manufacturers (2020-2025)
 Table 12. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Closed-loop Automated Insulin Delivery (AID) System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Closed-loop Automated Insulin Delivery (AID) System as of 2024)
 Table 16. Global Closed-loop Automated Insulin Delivery (AID) System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Closed-loop Automated Insulin Delivery (AID) System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base and Headquarters
 Table 19. Global Closed-loop Automated Insulin Delivery (AID) System Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2020-2025) & (K Units)
 Table 23. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2026-2031) & (K Units)
 Table 24. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Closed-loop Automated Insulin Delivery (AID) System ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2020-2025) & (K Units)
 Table 29. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2026-2031) & (K Units)
 Table 30. Closed-loop Automated Insulin Delivery (AID) System High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Closed-loop Automated Insulin Delivery (AID) System ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Closed-loop Automated Insulin Delivery (AID) System Growth Accelerators and Market Barriers
 Table 37. North America Closed-loop Automated Insulin Delivery (AID) System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Closed-loop Automated Insulin Delivery (AID) System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Closed-loop Automated Insulin Delivery (AID) System Growth Accelerators and Market Barriers
 Table 40. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Closed-loop Automated Insulin Delivery (AID) System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Closed-loop Automated Insulin Delivery (AID) System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Closed-loop Automated Insulin Delivery (AID) System Investment Opportunities and Key Challenges
 Table 47. Central and South America Closed-loop Automated Insulin Delivery (AID) System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Medtronic Corporation Information
 Table 51. Medtronic Description and Major Businesses
 Table 52. Medtronic Product Models, Descriptions and Specifications
 Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Medtronic Sales Value Proportion by Product in 2024
 Table 55. Medtronic Sales Value Proportion by Application in 2024
 Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 57. Medtronic Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
 Table 58. Medtronic Recent Developments
 Table 59. Tandem Diabetes Care Corporation Information
 Table 60. Tandem Diabetes Care Description and Major Businesses
 Table 61. Tandem Diabetes Care Product Models, Descriptions and Specifications
 Table 62. Tandem Diabetes Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Tandem Diabetes Care Sales Value Proportion by Product in 2024
 Table 64. Tandem Diabetes Care Sales Value Proportion by Application in 2024
 Table 65. Tandem Diabetes Care Sales Value Proportion by Geographic Area in 2024
 Table 66. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
 Table 67. Tandem Diabetes Care Recent Developments
 Table 68. Admetsys Corporation Information
 Table 69. Admetsys Description and Major Businesses
 Table 70. Admetsys Product Models, Descriptions and Specifications
 Table 71. Admetsys Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Admetsys Sales Value Proportion by Product in 2024
 Table 73. Admetsys Sales Value Proportion by Application in 2024
 Table 74. Admetsys Sales Value Proportion by Geographic Area in 2024
 Table 75. Admetsys Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
 Table 76. Admetsys Recent Developments
 Table 77. Insulet Corporation Information
 Table 78. Insulet Description and Major Businesses
 Table 79. Insulet Product Models, Descriptions and Specifications
 Table 80. Insulet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Insulet Sales Value Proportion by Product in 2024
 Table 82. Insulet Sales Value Proportion by Application in 2024
 Table 83. Insulet Sales Value Proportion by Geographic Area in 2024
 Table 84. Insulet Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
 Table 85. Insulet Recent Developments
 Table 86. Defymed Corporation Information
 Table 87. Defymed Description and Major Businesses
 Table 88. Defymed Product Models, Descriptions and Specifications
 Table 89. Defymed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Defymed Sales Value Proportion by Product in 2024
 Table 91. Defymed Sales Value Proportion by Application in 2024
 Table 92. Defymed Sales Value Proportion by Geographic Area in 2024
 Table 93. Defymed Closed-loop Automated Insulin Delivery (AID) System SWOT Analysis
 Table 94. Defymed Recent Developments
 Table 95. Beta Bionics (iLet) Corporation Information
 Table 96. Beta Bionics (iLet) Description and Major Businesses
 Table 97. Beta Bionics (iLet) Product Models, Descriptions and Specifications
 Table 98. Beta Bionics (iLet) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Beta Bionics (iLet) Recent Developments
 Table 100. Bigfoot Biomedical Corporation Information
 Table 101. Bigfoot Biomedical Description and Major Businesses
 Table 102. Bigfoot Biomedical Product Models, Descriptions and Specifications
 Table 103. Bigfoot Biomedical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Bigfoot Biomedical Recent Developments
 Table 105. Dexcom Corporation Information
 Table 106. Dexcom Description and Major Businesses
 Table 107. Dexcom Product Models, Descriptions and Specifications
 Table 108. Dexcom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Dexcom Recent Developments
 Table 110. MicroTech Medical (Hangzhou) Co., Ltd. Corporation Information
 Table 111. MicroTech Medical (Hangzhou) Co., Ltd. Description and Major Businesses
 Table 112. MicroTech Medical (Hangzhou) Co., Ltd. Product Models, Descriptions and Specifications
 Table 113. MicroTech Medical (Hangzhou) Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments
 Table 115. Medtrum Corporation Information
 Table 116. Medtrum Description and Major Businesses
 Table 117. Medtrum Product Models, Descriptions and Specifications
 Table 118. Medtrum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Medtrum Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Closed-loop Automated Insulin Delivery (AID) System Product Picture
 Figure 2. Global Closed-loop Automated Insulin Delivery (AID) System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Hybrid Closed Loop Systems Product Picture
 Figure 4. DIY Closed Loop Systems Product Picture
 Figure 5. Global Closed-loop Automated Insulin Delivery (AID) System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Children with Type 1 Diabetes
 Figure 7. Adults with Type 1 Diabetes
 Figure 8. Closed-loop Automated Insulin Delivery (AID) System Report Years Considered
 Figure 9. Global Closed-loop Automated Insulin Delivery (AID) System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Closed-loop Automated Insulin Delivery (AID) System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Region (2020-2031)
 Figure 13. Global Closed-loop Automated Insulin Delivery (AID) System Sales (2020-2031) & (K Units)
 Figure 14. Global Closed-loop Automated Insulin Delivery (AID) System Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 15. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Closed-loop Automated Insulin Delivery (AID) System Sales Volume Market Share in 2024
 Figure 17. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Hybrid Closed Loop Systems Revenue Market Share by Manufacturer in 2024
 Figure 20. DIY Closed Loop Systems Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2020-2031)
 Figure 22. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type (2020-2031)
 Figure 23. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2020-2031)
 Figure 24. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application (2020-2031)
 Figure 25. North America Closed-loop Automated Insulin Delivery (AID) System Sales YoY (2020-2031) & (K Units)
 Figure 26. North America Closed-loop Automated Insulin Delivery (AID) System Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) in 2024
 Figure 28. North America Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Type (2020- 2031)
 Figure 29. North America Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Application (2020-2031)
 Figure 31. North America Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Closed-loop Automated Insulin Delivery (AID) System Sales YoY (2020-2031) & (K Units)
 Figure 36. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Type (2020-2031)
 Figure 39. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Application (2020-2031)
 Figure 41. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 43. France Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales YoY (2020-2031) & (K Units)
 Figure 48. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 58. India Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Closed-loop Automated Insulin Delivery (AID) System Sales YoY (2020-2031) & (K Units)
 Figure 60. Central and South America Closed-loop Automated Insulin Delivery (AID) System Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Type (2021-2031)
 Figure 63. Central and South America Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Application (2020-2031)
 Figure 65. Central and South America Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Closed-loop Automated Insulin Delivery (AID) System Sales YoY (2020-2031) & (K Units)
 Figure 69. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Type (2021-2031)
 Figure 72. South America Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales Volume (K Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Closed-loop Automated Insulin Delivery (AID) System Revenue (2020-2025) & (US$ Million)
 Figure 79. Closed-loop Automated Insulin Delivery (AID) System Industry Chain Mapping
 Figure 80. Regional Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base Distribution (%)
 Figure 81. Global Closed-loop Automated Insulin Delivery (AID) System Production Market Share by Region (2020-2031)
 Figure 82. Closed-loop Automated Insulin Delivery (AID) System Production Process
 Figure 83. Regional Closed-loop Automated Insulin Delivery (AID) System Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Automatic Insulin Delivery Systems Market Insights Forecast to 2030
Global Artificial Pancreas Closed Loop System Market Research Report 2024
Global Smart Insulin Infusion Pumps Market Research Report 2024
Global Closed Loop Artificial Pancreas System Market Research Report 2024
Global Automated Insulin Delivery Device Market Research Report 2024
Global Hybrid Closed loop Insulin Delivery System Market Research Report 2024
Global Automated Insulin Delivery Systems Market Research Report 2024
Global Diabetes Treatment Medical Devices Market Research Report 2024
Global Human Insulin Delivery System Market Insights Forecast to 2030
Global Insulin Pump Market Research Report 2025
Global Diabetes Insulin Pumps Market Research Report 2024
Artificially Intelligent Insulin Pump Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Management System Market Insights Forecast to 2030
Global Insulin Injection Equipment Market Research Report 2025
Automatic Insulin Dosing Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Pump and Supplies Market Research Report 2024
Global Wearable Insulin Pump Market Research Report 2025
Global Insulin Pumps and Accessories Market Research Report 2024
Global Tube Insulin Pumps Market Research Report 2024
Smart Insulin Pump Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions